Company Overview

Vireo Growth Inc. is a U.S.-focused, vertically integrated cannabis company operating primarily in regulated medical and adult-use cannabis markets. The company cultivates, manufactures, and retails cannabis products, serving patients and consumers through state-licensed operations. Its core activities span cultivation, processing, branded product development, and direct-to-consumer retail, positioning the company across multiple points of the cannabis value chain.

Formerly known as Vireo Health International, the company rebranded to Vireo Growth Inc. to reflect a sharper focus on disciplined growth and U.S. market operations. Vireo has emphasized compliance-driven operations in limited-license states, leveraging early market entry and medical cannabis expertise as strategic advantages. Its history reflects a transition from early-stage market development to operational optimization amid evolving U.S. cannabis regulations.

Business Operations

Vireo Growth Inc. generates revenue through its vertically integrated operations, including cannabis cultivation, product manufacturing, wholesale distribution, and retail dispensaries. The company operates under the Vireo Health platform, with state-level subsidiaries holding cultivation and retail licenses. Retail operations are conducted through branded dispensaries, including Green Goods, which serves as a primary consumer-facing business unit in several states.

Operations are concentrated in select U.S. jurisdictions with regulated cannabis programs, and the company has historically prioritized medical cannabis markets while expanding into adult-use where legally permitted. Vireo controls cultivation facilities, manufacturing assets, and retail locations, allowing for cost control and product consistency. Data regarding active joint ventures or third-party partnerships is limited; public disclosures indicate the company primarily operates through wholly owned subsidiaries rather than large-scale joint ventures.

Strategic Position & Investments

Vireo’s strategic direction centers on achieving sustainable profitability, strengthening balance sheet discipline, and selectively expanding in existing markets rather than aggressive multi-state expansion. Growth initiatives have included capacity optimization, product portfolio expansion, and preparation for adult-use market conversions in states transitioning from medical-only frameworks.

The company has completed acquisitions historically to establish market entry in limited-license states; however, recent strategy emphasizes organic growth and operational efficiency over large acquisitions. Notable subsidiaries operate under the Vireo Health brand at the state level. Public information on investments in emerging cannabis-adjacent technologies is limited; data inconclusive based on available public sources regarding material investments outside core cannabis operations.

Geographic Footprint

Vireo Growth Inc. operates exclusively within the United States, with a presence in multiple regulated cannabis states. Key markets have included Minnesota, New York, New Mexico, and Maryland, where the company maintains cultivation, manufacturing, and/or retail operations. The company has previously divested or exited certain markets as part of its strategic refocusing, indicating a selective geographic approach.

Corporate headquarters and executive leadership are based in the United States, and the company does not maintain international cultivation or retail operations. Its geographic footprint reflects a concentration on jurisdictions with structured regulatory frameworks and opportunities for long-term license value rather than broad continental coverage.

Leadership & Governance

Vireo Growth Inc. was founded by Kyle Kingsley, who has played a central role in shaping the company’s medical-first and compliance-oriented philosophy. Leadership emphasizes physician-informed product development, regulatory engagement, and cautious capital allocation aligned with long-term market maturation.

Key executives include:

• Kyle Kingsley – Chief Executive Officer
• John Mazarakis – Chief Financial Officer

Public disclosures confirm the CEO and CFO roles; information on additional executive officers is inconsistent across available public sources, and data is inconclusive based on available public sources regarding other current C-suite appointments beyond those listed.